NXTC
NXTC
NASDAQ · Biotechnology

Nextcure Inc

$11.10
+0.01 (+0.09%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.98M 7.00M 7.72M
Net Income -1,326,181 -1,545,557 -1,571,652
EPS
Profit Margin -19.0% -22.1% -20.4%
Rev Growth +10.9% +1.3% +2.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.62M 4.77M 6.06M
Total Equity 26.87M 26.41M 26.59M
D/E Ratio 0.21 0.18 0.23
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,878,590 -1,945,549 -2,406,257
Free Cash Flow -1,092,947 -1,597,568 -1,077,092